Seattle area philanthropists responded to COVID-19 care and research needs
On Apr. 6, 2020, the University of Washington Medicine (UW) announced that more than $20 million has been…
-
-
Alzheimer’s trial screening data links high amyloid levels with early stage disease
On Apr. 6, 2020, the first published data from the Anti-Amyloid Treatment in Asymptomatic Alzheimer’s Disease (A4) study…
-
FDA cleared Mesoblast IND for remestemcel use in COVID-19 ARDS patients
On Apr. 6, 2020, Mesoblast announced it had received clearance from the U.S. Food and Drug Administration (FDA)…
-
Mateon achieved milestone in development of OT-101, a phase 3 clinical drug candidate, against COVID-19
On Apr. 6, 2020, Mateon Therapeutics announced that it has delivered the requisite testing results to Golden Mountain…
-
Minneapolis Heart Institute Foundation engaged in COVID-19 STEMI research study
On Apr. 6, 2020, the Minneapolis Heart Institute Foundation (MHIF) announced it was serving as the international coordinating…
-
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Influenza | Non-Profit Research | Therapeutics
Mesa Biotech to develop molecular point-of-care diagnostic test for novel Coronavirus (COVID-19)
On Apr. 4, 2020, Mesa Biotech announced the addition of the novel coronavirus (SARS-CoV-2) to its active influenza…
-
Mayo Clinic named national site for Convalescent Plasma Expanded Access Program
On Apr. 3, 2020, the FDA announced that the Mayo Clinic Mayo Clinic will be the lead institution…
-
OHSU launched in-house COVID-19 testing lab
On Apr. 3, 2020, Oregon Health & Science University (OHSU) announced that it had established an in-house COVID-19…
-
Mary and Ryan Finley donated $3 million to Legacy Health, OHSU to combat COVID-19
On Apr. 3, 2020, Oregon Health & Science University (OHSU) announced that Mary and Ryan Finley, moved by…
-
Penn Medicine launched trial to evaluate hydroxychloroquine to treat, prevent COVID-19
On Apr. 6, 2020, a trial led by the Perelman School of Medicine at the University of Pennsylvania…
-
Texas A&M Researchers designed 3D-printed diffuser to treat COVID-19 patients
On Apr. 3, 2020, a team of Texas A&M University researchers led by Michael R. Moreno, in collaboration…
-
Incyte initiated phase 3 clinical trial of Ruxolitinib (Jakafi) as treatment for patients with COVID-19 cytokine storm
On Apr. 2, 2020, Incyte announced it was working with the U.S. Food and Drug Administration (FDA) to…
-
Emergent BioSolutions partnered with U.S. Government to expedite development of plasma-derived therapy for COVID-19
On Apr. 2, 2020, Emergent BioSolutions announced it had entered into a formal partnership with the U.S. government…
-
CHF Solutions doubled production staff of Aquadex SmartFlow consoles due to hospital demand
On Apr. 2, 2020, CHF Solutions announced it has doubled the production staff that builds its next generation…
-
Fred Hutch team launched hunt for coronavirus antibodies
On Apr. 2, 2020, a team of scientists at Fred Hutchinson Cancer Research Center in Seattle began searching…
-
Adaptive Biotechnologies and Amgen announced collaboration to address COVID-19 pandemic
On Apr. 2, 2020, Amgen and Adaptive Biotechnologies announced a collaboration aimed at helping address the COVID-19 pandemic….
-
Biotechnology | Diagnostics | Disease | Genomics | Neurology | NIH | Therapeutics
Single mutation leads to big effects in autism-related gene
On Apr. 2, 2020, a study in Neuron offers clues to why autism spectrum disorder (ASD) is more…
-
Novartis announced plan to initiate clinical study of Jakavi in severe COVID-19 patients and establish international compassionate use program
On Apr. 2, 2020, Novartis announced plans to initiate a phase III clinical trial in collaboration with Incyte…
-
Trial drug significantly blocked early stages of COVID-19 in engineered human tissues
On Apr. 2, 2020, an international team led by University of British Columbia (UBC) researcher Dr. Josef Penninger…
-
Vir and Alnylam expand collaboration to advance investigational RNAi therapeutics targeting host factors of COVID-19
On Apr. 2, 2020, Vir Biotech and Alnylam Pharma announced an expansion to their broad multi-target existing collaboration…
-
Cerus announced inclusion of pathogen reduction technology in ISBT recommendations for preparation of COVID-19 convalescent plasma
On Apr. 2, 2020, Cerus announced that the International Society of Blood Transfusion (ISBT) Working Party on Global…
-
Early study of COVID-19 patients showed high mortality rate
On Apr. 1, 2020, a University of Washington Medicine led study of 24 of the most critically ill…
-
Biotechnology | Genomics | NIH | Rare Disease | Therapeutics
NIH researchers discovered gene for rare disease of excess bone tissue growth
On Mar. 31, 2020, researchers at the National Institutes of Health announced they had discovered a second gene…
-
Fujifilm announced start of phase III clinical trial of influenza antiviral drug ‘Avigan Tablet’ on COVID-19 patients
On Mar. 31, 2020, FUJIFILM announced initiation of a phase III clinical trial to evaluate the safety and…
-
Philips to fulfill contract with the HHS for the delivery of 10,000 Trilogy Universal units with accelerated delivery
On Mar. 31, 2020, Philips announced that it was fully committed to fulfill the contract with the U.S….
-
VIVUS accelerated launch of telemedicine and remote monitoring modules to facilitate ‘Social Distancing’
On Mar. 31, 2020, VIVUS announced the accelerated launch of the telemedicine and remote monitoring modules of the…
-
Sorrento announced research testing agreement with University of Texas for preclinical testing of COVID-19 therapeutic product candidates
On Mar. 31, 2020, Sorrento announced it had entered into a research testing agreement with The University of…
-
Kleo Pharmaceuticals announced research collaboration with Green Cross LabCell to develop COVID-19-targeting allogeneic NK Cell combination therapy
On Mar. 31, 2020, Kleo Pharmaceuticals announced it had entered into a research collaboration with South Korea -based…
-
Amgen established Amgen Astellas BioPharma as wholly-owned affiliate In Japan
On Mar. 31, 2020, Amgen announced it had consummated the purchase from Astellas of 49% of shares of…
-
Biotechnology | Diagnostics | Infectious Disease | Medicine | Non-Profit Research | Therapeutics | Vaccine
Citizen scientists helped researchers design new drugs to combat COVID-19
On Mar. 30, 2020, Howard Hughes Medical Institute Investigator David Baker created new proteins tailor-made for specific tasks….
